April 30, 2009
Posted by: admin : Category:
Object
The FDA announced today that it will require black box labeling on Botox and similar products warning of a rare, but potentially life threatening complication when the effects of the toxin spread far beyond the injection site.
Excerpt from:ÂÂ
Black Box Warning for Botox
April 30, 2009
Posted by: admin : Category:
General
BOSTON (MarketWatch) — The Food and Drug Adminstration said Thursday that it is requiring makers of Botox and rival products to display tougher warnings on their labels advising the products may trigger certain dangerous side effects.
View original here:
FDA toughens warnings on Botox-like products - MarketWatch
April 30, 2009
Posted by: admin : Category:
Botox,
General
The FDA has approved a competitor to Allergan’s Botox . The new wrinkle-fighting drug will be marketed by Medicis as Dysport.
See original here:
Allergan Could Lose a Third of Botox Market With FDA's Approval of …